EX-99.A 2 d231129dex99a.htm EXHIBIT A Exhibit A

Exhibit A

AGREEMENT

The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value, of Voyager Therapeutics, Inc. shall be filed on behalf of the undersigned.

 

Armistice Capital, LLC
By:  

/s/ Steven Boyd

Steven Boyd
Managing Member

/s/ Steven Boyd

Steven Boyd